China National Accord Medicines Corp Ltd
SZSE:000028
China National Accord Medicines Corp Ltd
Interest Income Expense
China National Accord Medicines Corp Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Interest Income Expense
¥27.4m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Interest Income Expense
-¥3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Interest Income Expense
-¥1.1B
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Interest Income Expense
-¥1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-14%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Interest Income Expense
¥526.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Interest Income Expense
-¥248.5m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-20%
|
See Also
What is China National Accord Medicines Corp Ltd's Interest Income Expense?
Interest Income Expense
27.4m
CNY
Based on the financial report for Mar 31, 2024, China National Accord Medicines Corp Ltd's Interest Income Expense amounts to 27.4m CNY.
What is China National Accord Medicines Corp Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-33%
Over the last year, the Interest Income Expense growth was -55%. The average annual Interest Income Expense growth rates for China National Accord Medicines Corp Ltd have been -47% over the past three years , -33% over the past five years .